These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 27860280)
1. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors. Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory. Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors. Duan YT; Wang ZC; Sang YL; Tao XX; Teraiya SB; Wang PF; Wen Q; Zhou XJ; Ding L; Yang YH; Zhu HL Eur J Med Chem; 2014 Apr; 76():387-96. PubMed ID: 24594526 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors. Qin YJ; Wang PF; Makawana JA; Wang ZC; Wang ZN; Yan-Gu ; Jiang AQ; Zhu HL Bioorg Med Chem Lett; 2014 Nov; 24(22):5279-83. PubMed ID: 25587588 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors. Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity. Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and molecular docking of 1,4-benzodioxane thiazolidinedione piperazine derivatives as FabH inhibitors. Sun J; He W; Liu HY; Qin J; Ye CL Bioorg Chem; 2019 Jul; 88():102958. PubMed ID: 31054434 [TBL] [Abstract][Full Text] [Related]
9. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination. Wang YT; Shi TQ; Fu J; Zhu HL Eur J Med Chem; 2019 Jun; 171():209-220. PubMed ID: 30925337 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors. Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors. Luo Y; Zhang LR; Hu Y; Zhang S; Fu J; Wang XM; Zhu HL ChemMedChem; 2012 Sep; 7(9):1587-93. PubMed ID: 22811397 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929 [TBL] [Abstract][Full Text] [Related]
13. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking. Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975 [TBL] [Abstract][Full Text] [Related]
14. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH. Yang YS; Su MM; Xu JF; Liu QX; Bai LF; Hu XW; Zhu HL Bioorg Chem; 2019 Dec; 93():103309. PubMed ID: 31585266 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea. Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479 [TBL] [Abstract][Full Text] [Related]
16. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors. Segretti ND; Serafim RA; Segretti MC; Miyata M; Coelho FR; Augusto O; Ferreira EI Bioorg Med Chem Lett; 2016 Aug; 26(16):3988-93. PubMed ID: 27426865 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents. Zhang HJ; Zhu DD; Li ZL; Sun J; Zhu HL Bioorg Med Chem; 2011 Aug; 19(15):4513-9. PubMed ID: 21741250 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents. Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983 [TBL] [Abstract][Full Text] [Related]
20. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies. Ramamoorthy D; Turos E; Guida WC J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]